AACR: After blood cancer successes, CAR-T treatments see inroads for solid cancers

CAR-T has seen a host of successes in blood cancers, but translating that into solid tumors has proven much more difficult. Now, early data out of the AACR cancer conference (and all the caveats that brings) may be offering some hope for that direction.